Jordana A. Reis-Dos

6627, Antônio Carlos Ave
Belo Horizonte, MG 31270901, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Phenotypic characterization of mucosal-associated invariant T cells in visceral leishmaniasis and HIV co-infection.

Phenotypic characterization of mucosal-associated invariant T cells in visceral leishmaniasis and HIV co-infection.

Journal: Frontiers in immunology

Published: May 15, 2026

SARS-CoV-2 drives upregulation of EpCAM in respiratory epithelial cells with hypercellular profile during severe COVID-19.

SARS-CoV-2 drives upregulation of EpCAM in respiratory epithelial cells with hypercellular profile during severe COVID-19.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: December 20, 2025

Immune landscape of COVID-19 recovery: Nucleocapsid as a major target of CD8+ T cell antiviral responses in convalescent HLA-A*02+ individuals from Brazil.

Immune landscape of COVID-19 recovery: Nucleocapsid as a major target of CD8+ T cell antiviral responses in convalescent HLA-A*02+ individuals from Brazil.

Journal: Journal of leukocyte biology

Published: December 16, 2025

Clinical, Serological, and Molecular Profile of Dengue Patients With Warning Signs During the 2024 Outbreak in Belo Horizonte, Brazil.

Clinical, Serological, and Molecular Profile of Dengue Patients With Warning Signs During the 2024 Outbreak in Belo Horizonte, Brazil.

Journal: Journal of medical virology

Published: December 11, 2025

Baseline immune signatures are associated with prospective COVID-19 infection and clinical outcomes in healthcare workers: Evidence from a cohort study in Brazil.

Baseline immune signatures are associated with prospective COVID-19 infection and clinical outcomes in healthcare workers: Evidence from a cohort study in Brazil.

Journal: Immunology letters

Published: October 22, 2025

FC-duplex IgG1 (HTLV-1/2): Qualifying the flow cytometry IgG1 duplex assay for differential diagnosis of HTLV-1 and HTLV-2 infections.

FC-duplex IgG1 (HTLV-1/2): Qualifying the flow cytometry IgG1 duplex assay for differential diagnosis of HTLV-1 and HTLV-2 infections.

Journal: PLoS neglected tropical diseases

Published: October 15, 2025

Cannabidiol promotes fine-tuning of natural killer and monocytic cells subsets as well as cytokine storm during chikungunya virus exposure in vitro: Insights for putative therapeutic interventions.

Cannabidiol promotes fine-tuning of natural killer and monocytic cells subsets as well as cytokine storm during chikungunya virus exposure in vitro: Insights for putative therapeutic interventions.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 29, 2025

New aminoadamantane derivatives as inhibitors of F13 envelope protein from mpox virus.

New aminoadamantane derivatives as inhibitors of F13 envelope protein from mpox virus.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 25, 2025

Distinct CD8+ T cell types associated with COVID-19 severity in unvaccinated HLA-A2+ patients.

Distinct CD8+ T cell types associated with COVID-19 severity in unvaccinated HLA-A2+ patients.

Journal: iScience

Published: July 28, 2025

Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana Study.

Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana Study.

Journal: Vaccines

Published: May 12, 2025

Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana Study.

Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana Study.

Journal: Vaccines

Published: May 12, 2025

Correction to: HCV immunodominant peptide mapping reveals unique HLA‑A* 02‑restricted signatures: insights for CD8+ T‑cell‑based vaccines and immunotherapies.

Correction to: HCV immunodominant peptide mapping reveals unique HLA‑A* 02‑restricted signatures: insights for CD8+ T‑cell‑based vaccines and immunotherapies.

Journal: Immunogenetics

Published: April 22, 2025

Showing 1-12 of 62

Last Updated: 09/26/2026